Related Experiment Video
Updated: Jan 30, 2026

Predictive Measurement for Windlass Change in Length and Selected Treatment Outcomes in Chronic Plantar Fasciitis
Published on: March 1, 2024
Changing Hearts and Minds: Improving Outcomes in Cancer Treatment-Related Cardiotoxicity
Nonniekaye Shelburne1,2, Naoko I Simonds3, Bishow Adhikari4
1Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, MD, USA. nshelburne@nih.gov.
Insights
Cancer treatments can harm the heart, causing serious health issues for survivors. Recent research highlights progress and identifies new priorities for preventing and managing cancer treatment-related cardiotoxicity.
Area of Science:
- Cardiology
- Oncology
- Translational Science
Background:
- Cardiotoxicity from cancer therapies is a significant cause of morbidity and mortality in cancer survivors.
- Previous workshops in 2013 and 2018 identified key challenges and research directions.
Purpose of the Study:
- To review advances in understanding and managing cancer treatment-related cardiotoxicity since 2013.
- To outline updated scientific priorities for future research in this field.
Main Methods:
- Convening of a "Changing Hearts and Minds" Workshop by the National Cancer Institute and National Heart, Lung, and Blood Institute in June 2018.
- Review of progress in basic and clinical cardiotoxicity research.
- Identification of knowledge gaps and promising research opportunities.
Main Results:
- Increased National Institutes of Health funding and coordination for cardiotoxicity research since 2013.
- Identification of over 20 new research opportunities in basic and clinical cardiotoxicity.
- Significant progress in understanding mechanisms, detection, management, and prevention of cardiotoxicity.
Conclusions:
- Substantial progress has been made in addressing cancer treatment-related cardiotoxicity.
- Critical knowledge gaps remain, necessitating continued research and funding.
- Future research priorities have been identified to improve outcomes for cancer survivors.
Purpose Of Review:
Cardiovascular effects from cancer treatment remains a leading cause of treatment-associated morbidity and mortality among cancer survivors. The National Cancer Institute and National Heart, Lung, and Blood Institute convened a Workshop in June 2018 entitled "Changing Hearts and Minds: Improving Outcomes in Cancer Treatment-Related Cardiotoxicity" to highlight progress, ongoing work, and update scientific priorities since the 2013 Workshop. Here we will describe these advances and provide an overview of the research priorities identified.
Recent Findings:
Since 2013, the National Institutes of Health has increased its support of cancer treatment-related cardiotoxicity research through the funding of grants and coordination of internal and external working groups. Workshop participants identified knowledge gaps and recommended over 20 new promising opportunities in basic and clinical cardiotoxicity research. Significant progress on mechanisms, detection, management, and prevention of cardiotoxicity has been made over the past 5 years, yet some critical gaps remain.
More Related Videos
Related Concept Videos
Treatment Resistant Cancers
Predicting Reaction Outcomes
Outcomes of Glycolysis
Cellular respiration can occur aerobically (with oxygen) or anaerobically (without oxygen). In the presence of oxygen, cellular respiration starts with glycolysis and continues with pyruvate...
Global Climate Change
Net Change Theorem
Rates of Change

